Discover how AI-integrated medical devices are transforming healthcare by 2025 and beyond with advanced technologies and improved accessibility.

Riliprubart Earns Orphan Drug Designation in the US for Antibody-mediated Rejection in Solid Organ Transplantation This designation reflects Sanofi’s commitment to addressing a critical unmet need in ...

Regular physical activity is essential for maintaining a healthy lifestyle, especially for seniors. However, only some people are comfortable going to the gym or exercising outdoors, especially during ...

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

The healthcare sector has experienced significant transformations in recent years. From taking responsibility in critical situations to developing patient engagement platforms, healthcare ...

Selecting the appropriate nursing facility, also known as a nursing home, can be a challenging decision when considering the care of a parent. It’s important to recognize that no nursing home is ...

Nursing is a vital component of the healthcare sector. Nurses play a critical role in healthcare delivery. Their part in the medical care industry has become increasingly significant. They are ...

Medical Device News Magazine is a leading publication dedicated to providing comprehensive coverage of the medical device industry. Our magazine offers in-depth analysis, industry insights, and the ...

Conducted at Samsung Medical Center, the Phase 3 clinical trial enrolled 24 newly diagnosed Hunter Syndrome patients with no prior treatment. It evaluated the efficacy and safety of Hunterase over a ...

ENFLONSIA is the first and only RSV preventive option for administration to infants using the same dose regardless of weight. Ordering will begin in July, with shipments delivered before the start of ...

Unlike traditional nasal sprays that rely on steroids or antihistamines, LUCA V-Defense forms a non-medicated barrier across the nasal mucosa, the body’s first line of defense against airborne ...

This new clearance broadens the clinical utility of the Restrata platform, now supporting soft tissue reinforcement applications in addition to its previously cleared indications for wound healing.